At LifeLabs, we believe that personalized healthcare is the key to better patient outcomes. That’s why we’re excited to introduce our advanced Therapeutic Drug Monitoring (TDM) services. Designed to optimize treatment efficacy and safety, our TDM tests ensure that patients receive the right dosage of biologics and biosimilars.
We offer validated TDM testing (both Level and ADA) for the following drugs:
|
Biologic/Biosimilar molecule |
Brand name |
|
Infliximab |
Remicade |
|
Infliximab |
Inflectra |
|
Adalimumab |
Humira |
|
Adalimumab |
Amjevita |
We continuously validate and introduce new TDM tests; please reach out to us for an updated list.
LifeLabs serves as a comprehensive diagnostic support hub, offering fecal calprotectin and QuantiFERON TB Gold testing, along with a diverse menu of provincially covered tests for patients on biologics and biosimilars. With over 380 Patient Service Centres nationwide and a mobile collections service, LifeLabs ensures convenient, high-quality service and rapid results. Our TDM testing boasts exceptional turnaround times, and we provide comprehensive support at every stage.
Our testing solutions are highly customizable and can be tailored to your organization’s specific needs. Collaborate with us to develop your Patient Support Program (PSP) or enhance infusion clinic services.